Actively Recruiting
New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
Led by University Hospital, Grenoble · Updated on 2024-12-17
15
Participants Needed
1
Research Sites
61 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This descriptive qualitative study aim to describe the characteristics of pelvic pain in transgender (trans) individuals using testosterone therapy and the impact on their quality of life. This study also aim to understand the levers and obstacles to consulting a health care professional.
CONDITIONS
Official Title
New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Being a trans masculine individual
- Taking a gender affirming hormonal therapy (GAHT)
- Living close to Grenoble
- Having pelvic pain that appeared or was modified after taking GAHT
You will not qualify if you...
- Subject under guardianship or deprived of liberty
- Refusal of voice recording
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UGA
Saint-Martin-d'Hères, France, 38100
Actively Recruiting
Research Team
S
SaraEve Graham Longsworth, MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here